GC Aesthetics (GCA), a producer of silicone implants, has announced a new breast delivery device, designed to make the insertion of all silicone implants easier with minimal-touch delivery across a variety of different surgical approaches. 

HydroCone is a sterile single patient use device which features great benefits for surgeons. The inner surface coating is made of hyaluronic acid which becomes extremely slippery when hydrated with sterile saline solution, aiming to make the surgery more efficient. Employing a minimal-touch delivery technique may reduce postoperative complications.

Ron Cosmas, chief commercial officer (CCO), said: “As a global leader in the women’s health arena, with over 3,000,000 implants sold, it is now more than ever, more critical that GC Aesthetics works closely with our surgeons, educators and innovators to ensure patient safety. The addition of this elegantly simply device, is the first of many additions to the GCA portfolio in 2020 and H-1, 2021.   

“The addition of the HydroCone to the GCA portfolio further exemplifies our commitment to patient safety, while maximising surgical efficiency and efficacy. Surgeons across the EU will soon have access to a device which is designed to minimise skin/implant contact, while circumferentially distributing the localised force applied on an implant at time of insertion.”  

GC Aesthetics will be holding live workshops and virtual events to educate customers on the benefits of using breast implant delivery devices in surgery as well as guiding surgeons from consultation to surgery to recovery. 

HydroCone will first be available in the French, Spanish, German and Italian markets. Coverage to additional markets is expected to be rolled out later in the year.